Brief: Phio Pharmaceuticals Announces $4 Million Concurrent Registered Direct Offering And Private Placement Priced At-The-Market Under Nasdaq Rules
31/05/2023 13:14
May 31 (Reuters) - Phio Pharmaceuticals Corp PHIO.O :
* PHIO PHARMACEUTICALS ANNOUNCES $4 MILLION CONCURRENT
REGISTERED
DIRECT OFFERING AND PRIVATE PLACEMENT PRICED AT-THE-MARKET UNDER
NASDAQ RULES
* PHIO PHARMACEUTICALS - ENTERED INTO AGREEMENTS FOR SALE OF
233,646 OF SHARES OF COMMON STOCK AT PRICE OF $4.28/ SHARE IN
REGISTERED DIRECT OFFERING
Source text for Eikon: ID:nPn2WlHD7a
Further company coverage: PHIO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Phio Pharmaceuticals
See all newsPhio Pharmaceuticals Q1 net loss widens on higher R&D costs
Brief: Phio Pharmaceuticals Corp - Enters At The Market Offering Agreement With H.C. Wainwright On April 8, 2026
Brief: Phio Pharmaceuticals Corp Announces Key Tumor Response Data From PH-762 Trial
Brief: Phio Pharmaceuticals Corp To Begin Toxicology Study For Ph-762 Before Human Trials - SEC Filing
Brief: Phio Pharmaceuticals Corp Files For Offering Of Up To 11.8 Million Common Shares By The Selling Stockholders - SEC Filing